Bellevue Life Sciences Stock Number Of Shares Shorted
| BLACW Stock | 0.04 0 7.65% |
Bellevue Life Sciences fundamentals help investors to digest information that contributes to Bellevue Life's financial success or failures. It also enables traders to predict the movement of Bellevue Stock. The fundamental analysis module provides a way to measure Bellevue Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bellevue Life stock.
Bellevue | Number Of Shares Shorted |
Bellevue Life Sciences Company Number Of Shares Shorted Analysis
Bellevue Life's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Bellevue Life Number Of Shares Shorted | 3 |
Most of Bellevue Life's fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bellevue Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Bellevue Number Of Shares Shorted Driver Correlations
Understanding the fundamental principles of building solid financial models for Bellevue Life is extremely important. It helps to project a fair market value of Bellevue Stock properly, considering its historical fundamentals such as Number Of Shares Shorted. Since Bellevue Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Bellevue Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Bellevue Life's interrelated accounts and indicators.
Click cells to compare fundamentals
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Bellevue Life Sciences has 3.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
Bellevue Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bellevue Life's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bellevue Life could also be used in its relative valuation, which is a method of valuing Bellevue Life by comparing valuation metrics of similar companies.Bellevue Life is currently under evaluation in number of shares shorted category among its peers.
Bellevue Fundamentals
| Number Of Shares Shorted | 3 | |||
| EBITDA | (35.39 K) | |||
| Net Income | 403.78 K | |||
| Total Debt | 4.11 M | |||
| Cash Flow From Operations | (818.77 K) | |||
| Total Asset | 36.63 M | |||
| Retained Earnings | (3.91 M) | |||
| Working Capital | (2.02 M) | |||
| Net Asset | 36.63 M |
About Bellevue Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bellevue Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bellevue Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bellevue Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Bellevue Stock Analysis
When running Bellevue Life's price analysis, check to measure Bellevue Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellevue Life is operating at the current time. Most of Bellevue Life's value examination focuses on studying past and present price action to predict the probability of Bellevue Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bellevue Life's price. Additionally, you may evaluate how the addition of Bellevue Life to your portfolios can decrease your overall portfolio volatility.